[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100528451":3},{"organization":4,"armGroups":7,"interventions":20,"overallOfficials":28,"centralContacts":35,"locations":45,"responsibleParty":66,"collaborators":68,"id":85,"slug":86,"hasResults":87,"nctId":88,"briefTitle":89,"officialTitle":90,"acronym":91,"eligibilityCriteria":92,"healthyVolunteers":87,"sex":93,"minAge":94,"maxAge":24,"enrollmentInfo":95,"targetDuration":24,"studyType":98,"phases":99,"briefSummary":101,"conditions":102,"keywords":104,"overallStatus":109,"whyStopped":24,"lastUpdateSubmitDate":110,"lastUpdatePostDateStruct":111,"startDateStruct":114,"completionDateStruct":116,"leadSponsor":118,"locationsCount":119},{"fullName":5,"class":6},"McMaster University","OTHER",[8,14],{"label":9,"type":10,"description":11,"interventionNames":12},"Usual Medical Care","ACTIVE_COMPARATOR","This group will consist of eligible, consenting, participants attending centers randomized to ongoing usual medical care.",[13],"Other: Usual Medical Care",{"label":15,"type":16,"description":17,"interventionNames":18},"Usual Medical Care + Chiropractic Care","EXPERIMENTAL","This group will consist of eligible, consenting, participants attending centers randomized to ongoing usual medical care plus chiropractic care.",[19],"Other: Usual Medical Care + Chiropractic Care",[21,25],{"type":6,"name":9,"description":22,"armGroupLabels":23,"otherNames":24},"In both the intervention and control arms of the study, usual medical care will be defined as any and all medical care provided to patients with chronic non-cancer back or neck pain at a Canadian CHC, including: primary care provider consultation visits, prescription medication (e.g., muscle relaxants, anti-inflammatories, anti-depressants, opioid and non-opioid analgesics), referral for diagnostic testing (e.g., lab work, imaging) or specialist consultation, as well as other co-interventions (e.g., visits with nurses, dieticians, social workers, or physiotherapists) as determined by their PCP. PCPs will also engage study participants in a formal effort to reduce their opioid use within the framework of each CHC's current opioid-reduction practices.",[9],null,{"type":6,"name":15,"description":26,"armGroupLabels":27,"otherNames":24},"Treatment sessions may include high-velocity, low-amplitude spinal manipulative therapy, as well as any or all of the following: spinal mobilization, soft-tissue massage\u002Ftrigger point therapy, education and reassurance (e.g., pain management, ergonomic and activities of daily living recommendations), and home advice (e.g., icing, spinal stretching, core muscle strengthening, and cardiovascular exercises). As part of the intervention, chiropractic clinicians will engage PCPs in a collaborative effort to support opioid tapering. Consistent with current clinical practice guidelines, participants will be provided up to a maximum of 18 chiropractic visits during the active care period, although participants may continue with treatment after the 12-week period (e.g., one visit, every 2-4 weeks) to manage episodes of exacerbation\u002Fflare-up.",[15],[29,32],{"name":30,"affiliation":5,"role":31},"Peter C Emary, DC, PhD","PRINCIPAL_INVESTIGATOR",{"name":33,"affiliation":5,"role":34},"Jason W Busse, DC, PhD","STUDY_DIRECTOR",[36,41],{"name":30,"role":37,"phone":38,"phoneExt":39,"email":40},"CONTACT","001-519-653-1470","352","emaryp@mcmaster.ca",{"name":33,"role":37,"phone":42,"phoneExt":43,"email":44},"001-905-525-9140","21731","bussejw@mcmaster.ca",[46],{"facility":5,"status":24,"city":47,"state":48,"zip":49,"country":50,"countryCode":51,"cosmosGeoPoint":52,"geoPoint":57,"contacts":58},"Hamilton","Ontario","L8S 4K1","Canada","CA",{"type":53,"coordinates":54},"Point",[55,56],-79.84963,43.25011,{"lat":56,"lon":55},[59,61,64],{"name":30,"role":37,"phone":60,"phoneExt":39,"email":40},"001-519-1470",{"name":62,"role":37,"phone":60,"phoneExt":39,"email":63},"Amy L Brown, DC","abrown@chiropractic.on.ca",{"name":62,"role":65,"phone":24,"phoneExt":24,"email":24},"SUB_INVESTIGATOR",{"type":31,"investigatorFullName":30,"investigatorTitle":67,"investigatorAffiliation":5,"oldNameTitle":24,"oldOrganization":24},"Postdoctoral fellow, Michael G. DeGroote National Pain Centre",[69,72,74,76,78,80,82],{"name":70,"class":71},"Surgical Methods Centre, McMaster University","UNKNOWN",{"name":73,"class":71},"Michael G. DeGroote Institute for Pain Research and Care",{"name":75,"class":71},"Ontario Chiropractic Association",{"name":77,"class":71},"Alliance for Healthier Communities",{"name":79,"class":71},"Michael G. DeGroote National Pain Centre",{"name":81,"class":6},"Canadian Chiropractic Research Foundation",{"name":83,"class":84},"Canadian Institutes of Health Research (CIHR)","OTHER_GOV","100528451","the-effect-of-chiropractic-care-on-opioid-use-for-chronic-spinal-pain-a-feasibility-study-100528451",false,"NCT06160947","The Effect of Chiropractic Care on Opioid Use for Chronic Spinal Pain: A Feasibility Study","Impact of Chiropractic Care on Opioid Use Among Adults With Chronic Non-Cancer Spinal Pain: A Pilot Cluster Randomized Controlled Trial (ACCESS-DC Pilot)","ACCESS-DC","Inclusion Criteria:\n\nClusters\n\n* CHC in Canada\n* Roster of ≥ 3,500 patients\n* One or more opioid-reducing strategies implemented as part of their standard medical services (e.g., chart audits, tracked performance metrics related to high dose prescribing)\n\nParticipants\n\n* Adult patients (aged ≥ 18 years)\n* Diagnosis of chronic non-cancer spinal pain (i.e., back or neck pain of ≥ 12 weeks' duration, not associated with cancer)\n* Actively receiving one or more opioid prescriptions (minimum dose of 50 mg MED, dispensed over a period of at least 3 consecutive months)\n* Interested in reducing their opioid dose\n* Cognitive ability and language skills required to complete the outcome measures\n* Provision of informed consent\n\nExclusion Criteria:\n\nClusters\n\n• CHCs that employ chiropractors or have currently established chiropractic programs\n\nParticipants\n\n* Individuals already receiving chiropractic care\n* Opioid-naive (or \\\u003C 90 consecutive days of opioid prescription) at baseline\n* Total active opioid dosage of \\\u003C 50 mg MED at baseline\n* Actively receiving treatment for opioid use disorder (e.g., methadone, naloxone)\n* Spinal neoplasms or other 'red flag' diagnoses (e.g., fractures, infections, inflammatory arthritis, or cauda equina syndrome)\n* Anticipated problems with the participant being available for follow-up (e.g., incarceration, or planned incarceration)\n* The participant is or may be enrolled in a competing trial\n* Prior enrolment in the ACCESS-DC trial\n* Other reason to exclude the participant, as approved by the Methods Centre","ALL","18 Years",{"count":96,"type":97},24,"ESTIMATED","INTERVENTIONAL",[100],"NA","The investigators will conduct a pilot cluster randomized controlled trial (RCT) of chiropractic care added to usual medical care, versus usual medical care alone, for adult patients prescribed opioid therapy for chronic non-cancer spinal pain at four community health centers (CHCs) in Canada. These centers provide services to communities and vulnerable populations with high unemployment rates, multiple co-morbidities, and high rates of chronic musculoskeletal disorders that are commonly managed with prescription opioids.\n\nThe investigators hypothesize that a full-scale (definitive) cluster RCT on the impact of chiropractic care on prescription opioid use for chronic non-cancer spinal pain will be feasible within the Canadian CHC context.",[103],"Back Pain",[105,106,107,108],"Clinical trials, randomized","Feasibility study","Analgesics, opioid","Chiropractic","NOT_YET_RECRUITING","2026-01-05",{"date":112,"type":113},"2026-01-07","ACTUAL",{"date":115,"type":97},"2026-04-01",{"date":117,"type":97},"2028-03-31",{"name":5,"class":6},1]